Teaching NeuroImages: Sacral spine chloroma
Citation Manager Formats
Make Comment
See Comments

A 23-year-old man with recurrent acute myeloid leukemia (AML) underwent successful reinduction and was judged posttherapy to be in complete remission. Soon thereafter, he complained of pain in his left buttock radiating into his left posterior thigh. Neurologic examination was unremarkable. Radiographic evaluation demonstrated a left S2 lesion suggestive of a nerve sheath tumor (figure 1). An open biopsy was performed that revealed a chloroma pathologically (figure 2), sometimes referred to as a myeloid sarcoma.1,2 Most chloromas are found in patients with recurrent AML and are overwhelmingly intracranial.1 Infrequently, chloromas are paraspinal, and in this location present with epidural spinal cord compression.2 Intraspinal invasion by a chloroma is rare. Systemic evaluation confirmed recurrent AML, for which he was successfully treated with reinduction and whole-body irradiation followed by an allogeneic transplant. He is currently disease-free and neurologically asymptomatic 1 year posttransplant.
Coronal (A) and axial CT (C) images show left S2 nerve root enlargement (black arrowheads) with adjacent osseous erosion of the left S2 foramen (black arrow, C). Gadolinium-enhanced T1-weighted MRI with fat suppression shows corresponding sacral nerve root enhancement (white arrows) on coronal (B) and axial (D) images, consistent with sacral nerve chloroma.
Note the high nuclear: cytoplasmic ratio, irregular nuclei, frequent apoptosis, and scattered mitotic figures. Scale bars: medium power 0.4 mm; high power 20 μm.
AUTHOR CONTRIBUTIONS
Marc C. Chamberlain: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, accepts responsibility for conduct of research and final approval, acquisition of data, study supervision. Trent L. Tredway: analysis or interpretation of data, accepts responsibility for conduct of research and final approval, acquisition of data. Don Born: analysis or interpretation of data, accepts responsibility for conduct of research and final approval, acquisition of data. James R. Fink: drafting/revising the manuscript, accepts responsibility for conduct of research and final approval.
STUDY FUNDING
No targeted funding reported.
DISCLOSURE
The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
Footnotes
Download teaching slides: www.neurology.org
- © 2013 American Academy of Neurology
REFERENCES
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.